Cloning of African Trypanosomes in Mice Immunosuppressed by Cyclophosphamide Treatment

Chris J. Smith Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky 40292

Search for other papers by Chris J. Smith in
Current site
Google Scholar
PubMed
Close
,
Rita F. Levine Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky 40292

Search for other papers by Rita F. Levine in
Current site
Google Scholar
PubMed
Close
, and
John M. Mansfield Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, Kentucky 40292

Search for other papers by John M. Mansfield in
Current site
Google Scholar
PubMed
Close
Restricted access

abstract

Abstract. The use of cyclophosphamide-treated mice for purposes of cloning the African trypanosomes was assessed. C3HeB/FeJ mice were injected with 200 mg/kg cyclophosphamide (CY) 24–72 hours prior to infection with a single trypanosome isolated from Trypanosoma rhodesiense infected blood samples. All CY-treated mice exhibited depressed parasite-specific and antigen nonspecific B lymphocyte responses for a period of 10 days after CY exposure, which was a period of time sufficient to grow trypanosomes from a single organism to a fulminating parasitemia. Cloning efficiency was routinely 45% in these animals. Thus, our study demonstrates that CY-treated mice are a convenient and efficient vehicle for cloning African trypanosomes. Techniques which facilitate the selection of single trypanosomes from infected blood are also described in this report.

Author Notes

Save